Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.21 USD | +0.38% | +16.23% | +62.78% |
05-09 | Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.78% | 333M | |
+7.39% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.57% | 16.81B | |
+37.41% | 12.54B | |
-24.07% | 8.09B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- RBC Trims Verastem's Price Target to $3 From $5, Keeps Outperform, Speculative Risk Rating